Micron Solutions (MICRD) 10-K 30 Mar 20 2019 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2019	Mar. 20, 2020	Jun. 30, 2019
Document and Entity Information [Abstract]
Document Type	10-K
Document Annual Report	true
Current Fiscal Year End Date	--12-31
Document Period End Date	Dec. 31, 2019
Document Transition Report	false
Entity File Number	001-9731
Entity Registrant Name	MICRON SOLUTIONS INC /DE/
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	72-0925679
Entity Address, Address Line One	25 Sawyer Passway
Entity Address, City or Town	Fitchburg
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	01420
City Area Code	978
Local Phone Number	345-5000
Title of 12(b) Security	Common Stock, $0.01 par value
Trading Symbol	MICR
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 7,063,813
Entity Common Stock, Shares Outstanding		2,906,609
Entity Central Index Key	0000819689
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	FY
Amendment Flag	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 503	$ 1,715
Trade accounts receivable, net of allowance for doubtful accounts of $39,169 at December 31, 2019 and $40,000 at December 31, 2018	2,152,254	2,325,804
Inventories	2,468,648	3,685,059
Assets held for sale, net	0	688,750
Prepaid expenses and other current assets	257,859	389,390
Total current assets	4,879,264	7,090,718
Property, plant and equipment, net	3,801,916	5,131,773
Intangible assets, net	47,509	53,155
Other assets	5,645	5,140
Total assets	8,734,334	12,280,786
Current liabilities:
Revolving line of credit	1,274,299	2,025,592
Term notes payable, current portion, net	3,557,458	389,420
Accounts payable	841,068	1,200,298
Accrued expenses and other current liabilities	383,836	459,108
Contract liabilities, current portion	5,472	560,802
Total current liabilities	6,062,133	4,635,220
Long-term liabilities:
Term notes payable, non-current portion, net	0	3,557,458
Subordinated promissory notes, net	470,152	0
Total long-term liabilities	470,152	3,557,458
Total liabilities	6,532,285	8,192,678
Commitments and Contingencies
Shareholders' equity:
Preferred stock, $0.001 par value; 2,000,000 shares authorized, none issued	0	0
Common stock, $0.01 par value; 10,000,000 shares authorized; 3,926,491 issued, 2,906,609 outstanding at December 31, 2019 and 3,926,491 issued, 2,861,008 outstanding at December 31, 2018	39,265	39,265
Additional paid-in-capital	11,735,457	11,604,817
Treasury stock at cost, 1,019,882 shares at December 31, 2019 and 1,065,483 shares at December 31, 2018	(2,783,055)	(2,907,490)
Accumulated deficit	(6,789,618)	(4,648,484)
Total shareholders’ equity	2,202,049	4,088,108
Total liabilities and shareholders’ equity	$ 8,734,334	$ 12,280,786

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Consolidated Balance Sheets [Abstract]
Allowance for doubtful accounts receivable, current	$ 39,169	$ 40,000
Preferred stock, par value per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	0	0
Common stock, par value per share	$ 0.01	$ 0.01
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares issued	3,926,491	3,926,491
Common stock, shares outstanding	2,906,609	2,861,008
Treasury stock, shares	1,019,882	1,065,483

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Consolidated Statements of Operations [Abstract]
Net sales	$ 17,499,364	$ 19,564,981
Cost of sales	15,737,469	17,241,289
Gross profit	1,761,895	2,323,692
Selling and marketing	636,167	730,863
General and administrative	2,760,787	2,243,595
Research and development	80,357	106,814
Total operating expenses	3,477,311	3,081,272
Net income (loss) from operations	(1,715,416)	(757,580)
Other income (expense):
Interest expense	(431,544)	(391,437)
Other income (expense), net	5,826	52,878
Total other expense, net	(425,718)	(338,559)
Net income (loss) before income tax provision (benefit)	(2,141,134)	(1,096,139)
Income tax provision (benefit)		2,168
Net income (loss)	$ (2,141,134)	$ (1,098,307)
Earnings (loss) per share - basic and diluted	$ (0.74)	$ (0.39)
Weighted average common shares outstanding - basic and diluted	2,883,861	2,850,397

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity - USD ($)	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Deficit	Total
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2017	$ 39,265	$ 11,532,207	$ (2,966,798)	$ (3,536,186)	$ 5,068,488
Shares, Outstanding, Beginning Balance at Dec. 31, 2017	3,926,491		1,087,217
Share-based compensation		56,168			56,168
Issuance of common stock from treasury, shares			(21,734)
Issuance of common stock from treasury		16,442	$ 59,308		75,750
Net income (loss)				(1,098,307)	(1,098,307)
Stockholders' Equity Attributable to Parent, Ending Balance at Dec. 31, 2018	$ 39,265	11,604,817	$ (2,907,490)	(4,648,484)	4,088,108
Shares, Outstanding, Ending Balance at Dec. 31, 2018	3,926,491		1,065,483
Change in accounting principle - ASC 606				(13,991)	(13,991)
Share-based compensation		108,716			$ 108,716
Issuance of common stock from treasury, shares			(45,601)		0
Issuance of common stock from treasury		(13,894)	$ 124,435		$ 110,541
Issuance of warrants		35,818			35,818
Net income (loss)				(2,141,134)	(2,141,134)
Stockholders' Equity Attributable to Parent, Ending Balance at Dec. 31, 2019	$ 39,265	$ 11,735,457	$ (2,783,055)	$ (6,789,618)	$ 2,202,049
Shares, Outstanding, Ending Balance at Dec. 31, 2019	3,926,491		1,019,882

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities:
Net loss	$ (2,141,134)	$ (1,098,307)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Gain on sale of assets	(7,602)	(8,360)
Depreciation and amortization	1,463,443	1,504,037
Impairment of intangibles	0
Non-cash interest expense	94,392	62,120
Change in allowance for doubtful accounts	831	0
Share-based compensation expense	219,257	131,918
Changes in operating assets and liabilities:
Accounts receivable	172,719	269,444
Inventories	1,258,015	(348,121)
Prepaid expenses and other current and non-current assets	131,026	44,389
Accounts payable	(371,833)	(343,038)
Accrued expenses and other current liabilities	(83,367)	157,376
Contract liabilities	(555,329)	134,345
Net cash provided by operating activities	180,419	505,803
Cash flows from investing activities:
Purchases of property, plant and equipment	(169,131)	(801,884)
Proceeds from sale of property, plant and equipment	32,602	8,360
Proceeds from sale of assets held for sale	663,334	0
Cash paid for patents and trademarks	0	(2,661)
Net cash provided by (used in) investing activities	526,805	(796,185)
Cash flows from financing activities:
Payments on revolving line of credit, net	(751,293)	146,545
Payments on term notes payable	(457,143)	(419,047)
Payments of debt issuance costs	0	(42,389)
Proceeds from subordinated debt	500,000
(Payments on) subordinated debt		(350,000)
Net cash provided by (used in) financing activities	(708,436)	(664,891)
Net change in cash and cash equivalents	(1,212)	(955,273)
Cash and cash equivalents, beginning of period	1,715	956,988
Cash and cash equivalents, end of period	503	1,715
Supplemental Cash Flow Information
Cash paid for interest	353,343	313,425
Non-cash activities:
Issuance of common stock warrants in connection with subordinated notes payable	35,818
Issuance of treasury stock for directors' fees	110,541	75,750
Adjustment to accumulated deficit for change in accounting principle (ASC 606)	$ 0	$ (13,991)

Description of Business

Description of Business	12 Months Ended
	Dec. 31, 2019
Description of Business [Abstract]
Description of Business	1. De scription of Business  Micron Solutions ® , Inc., a Delaware corporation ("Micron Solutions"), through its wholly-owned Massachusetts operating subsidiary, Micron Products ® , Inc. (“Micron” and together with Micron Solutions, the "Company"), is a diversified contract manufacturing organization (“CMO”) that produces highly-engineered, innovative components requiring precision machining and thermoplastic injection molding. The Company manufactures components, devices and equipment for military, law enforcement, automotive and consumer products applications. The Company's products include silver/silver chloride coated and conductive resin sensors used as consumable component parts in the manufacture of integrated disposable electrophysiological sensors. The Company’s machining operations produce quick-turn, high volume and patient-specific orthopedic implant components and instruments as well as products for the defense industry. The Company has diversified manufacturing capabilities with the capacity to participate in full product life-cycle activities from early stage development and engineering and prototyping to full scale manufacturing as well as packaging and product fulfillment services.  The Company competes globally, with approximately 37% of its revenue derived from exports.  Liquidity and Management’s Plan  At December 31, 2019, the Company identified certain conditions and events which in the aggregate required management to perform an assessment of the Company’s ability to continue as a going concern. These conditions included the Company’s negative financial history and the Company’s ability to generate sufficient cash to support the Company’s operations and to meet debt service requirements under the Company’s credit agreement. As of December 31, 2019, the Company has $503 of cash and approximately $810,000 of borrowing capacity on its revolving line of credit (“Revolver”). As a result of the above factors, management has performed an analysis to evaluate the entity’s ability to continue as a going concern for one year after the financial statements issuance date.  Management’s analysis includes forecasting future revenues, expenditures and cash flows, taking into consideration past performance and the requirements under the credit agreement. Revenue and cash flow forecasts are dependent on the Company’s ability to fill booked orders, to close on new and expanded business, to improve overall financial performance and its ability to obtain alternative financing, which may include a sale/leaseback of certain real estate and equipment.  On March 12, 2020, the Company entered into the Fourth Amendment to the Credit and Security Agreement in which the quart erly debt service coverage ratio measurement requirements for 2020 were amended to lessen the burden of compliance and non-compliance with the debt service coverage ratio for the fourth quarter of 2019 was waived. See Note 6.  Based on management’s analysis, t he Company believes that cash flows from operations, together with existing working capital, booked orders, expense management, the Revolver and alternative financing options, which may include a sale/leaseback of certain real estate and equipment, will be sufficient to fund operations at current and projected levels and to repay debt obligations over the next twelve months. However, there can be no assurance that the Company will be able to do so.

Accounting Policies

Accounting Policies	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Accounting Polices	2. Accounting Policies  Principles of consolidation  The consolidated financial statements (the "financial statements") include the accounts of Micron Solutions, Inc. and its operating subsidiary, Micron Products, Inc. All intercompany balances and transactions have been eliminated in consolidation.  Use of estimates  The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.  Revenue recognition  The Company adopted ASU No. 2014-09, “Revenue from Contracts with Customers, Topic 606” (“Topic 606”) effective January 1, 2018 using the modified retrospective approach. Under the modified retrospective method, a cumulative effect of initially applying the new standard is recorded as an adjustment to the opening balance of retained earnings at the date of initial application. By electing to use this method, there is no restatement of the comparative periods presented (i.e., interim periods and fiscal year ending 2017). As permitted by Topic 606 transition guidance (outlined below), the Company has elected to apply the new standard only to contracts that were not completed contracts at the date of initial application, and therefore, the Company only evaluated those contracts that were in-process and not completed before January 1, 2018.  The Company determined that customer purchase orders represent contracts with a customer. For each contract, the Company considers the promise to transfer products, each of which are distinct, to be the identified performance obligations.  Shipping and handling activities for which the Company is responsible are not a separate promised service but instead are activities to fulfill the entity’s promise to transfer goods. Shipping and handling fees will be recognized at the same time as the related performance obligations are satisfied.  The Company determines the transaction price as the amount of consideration it expects to receive in exchange for transferring promised goods or services to the customer. If a contract includes a variable amount, such as a rebate, then the Company estimates the transaction price using either the expected value or the most likely amount of consideration to be received, depending upon the specific facts and circumstances. The Company includes estimated variable consideration in the transaction price only to the extent it is probable that a significant reversal of revenue will not occur when the uncertainty is resolved. The Company updates its estimate of variable consideration at the end of each reporting period to reflect changes in facts and circumstances.  The Company recognizes revenue at the point in time when it transfers control of the promised goods or services to the customer, which typically occurs once the product has shipped or has been delivered to the customer. For certain customer warehousing agreements, delivery is deemed to have occurred when the customer pulls inventory out of the warehouse for use in their production. Additionally, for certain customers, delivery is deemed to have occurred when items are delivered to bill and hold locations at the Company’s facility.  The Company evaluated the nature of any guarantees or warranties related to its contracts with customers. The Company provides an assurance-type warranty that only covers the products’ compliance with agreed-upon specifications and does not provide the customer with a service in addition to the assurance that the product complies with agreed-upon specifications.  Certain contracts contain prepayment terms that result in liabilities for customer deposits. Additionally, certain contracts provide for invoicing before all performance obligations have been fulfilled which results in deferred revenue. Customer deposits and advance invoicing are recorded as contract liabilities on the Company’s consolidated balance sheet.  The Company generally expenses sales commission when incurred because the amortization period would have been one year or less. These costs are recorded within selling and marketing expenses.  The Company does not disclose the value of unsatisfied performance obligations for contracts with an original expected duration of one year or less.  The implementation of Topic 606 affects the timing of certain revenue related transactions primarily resulting from the earlier recognition of the Company's tooling revenue and costs. Under legacy GAAP, the Company accounted for tooling as multiple element arrangements whereby revenue and cost were recognized over a period of time after the tool was completed. Upon adoption of ASU 2014-09, tooling sales and costs are now recognized at the point in time upon which the tool is complete and the Company has satisfied all its performance obligations under the contract.  As a result of the initial application of Topic 606 in 2018, the Company made an adjustment to its beginning accumulated deficit of ( $13,991 ) to recognize the remaining deferred revenue ( $18,333 ) and deferred costs ( $32,324 ) recorded as of December 31, 2017 relative to certain completed tooling sales.  During the twelve months ended December 31, 2019, the Company recognized as revenue $5 49,326 of amounts recorded as Contract Liabilities at December 31, 2018. During the twelve months ended December 31, 2018, the Company recognized as revenue $85,833 of amounts recorded as Contract Liabilities at December 31, 2017.  Fair value of financial instruments  The carrying amount reported in the balance sheets for cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair value due to the immediate or short-term nature of such instruments. The carrying value of debt approximates fair value since it provides for market terms and interest rates.  Concentration of credit risk  Financial instruments which potentially expose the Company to concentrations of credit risk consist primarily of accounts receivable and cash and cash equivalents. It is the Company’s policy to place its cash in high quality financial institutions. The Company does not believe significant credit risk exists above federally insured limits with respect to these institutions.  Accounts receivable are customer obligations due under normal trade terms. A large portion of the Company's products are sold to large diversified medical, military and automotive parts product manufacturers. The Company does not generally require collateral for its sales; however, the Company believes that its terms of sale provide adequate protection against credit risk.  During the year ended December 31, 2019 , the Company had net sales to two customers constituting 18% and 10% of total net sales. Accounts receivable from these two customers at December 31, 2019 was 16% and 9% , respectively, of the total accounts receivable balance at year end. During the year ended December 31, 2018 , the Company had net sales to three customers constituting 18%, 12% and 10% , respectively, of total net sales. Accounts receivable from these three customers at December 31, 2018 was 20%, 7% and 7% , respectively, of the total accounts receivable balance at year end.  The Company competes globally, with 37% of its revenue derived from exports in 2019. While some risks exist in foreign markets, the Company’s customers have historically been based in stable regions. The Company has agreements with certain foreign customers to hold inventory at customer locations where title and control transfers and revenue is recognized when the product is consumed by the customer. Accounts receivable insurance is used where available and appropriate to reduce risk in these markets.  Cash and cash equivalents  The Company considers all highly liquid investments with an original maturity of three months or less at the date of purchase to be cash equivalents. Cash and cash equivalents consist of cash on hand in high quality financial institutions The Company’s credit agreement provides for a daily sweep of cash balances against the balance of the Revolver (see Note 6).  Accounts receivable and allowance for doubtful accounts  Accounts receivable represent amounts invoiced by the Company. Management maintains an allowance for doubtful accounts based on information obtained regarding individual accounts and historical experience. Amounts deemed uncollectible are written off against the allowance for doubtful accounts. Inventories  The Company values its inventory at the lower of average cost, or net realizable value, and cost is determined using first in first out (FIFO) or, for sensors, using average cost. The Company reviews its inventory for quantities in excess of production requirements, for obsolescence and for compliance with internal quality specifications. A review of inventory on hand is made at least annually and obsolete inventory may be disposed of and/or recycled. Any adjustments to inventory would be equal to the difference between the cost of inventory and the estimated net realizable value based upon assumptions about future demand, market conditions and expected cost to distribute those products to market. The Company also has supply agreements with certain foreign customers to hold inventory at the customer’s warehouses.  Property, plant and equipment  Property, plant and equipment are recorded at cost and include expenditures which substantially extend their useful lives. Depreciation on property, plant and equipment is calculated using the straight-line method over the estimated useful lives of the assets. Expenditures for maintenance and repairs are charged to earnings as incurred. When equipment is retired or sold, the resulting gain or loss is reflected in earnings.  Fair value hierarchy  The Company groups its assets and liabilities measured at fair value in three levels, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value.  Level 1 – Valuation is based on quoted prices in active markets for identical assets or liabilities. Valuations are obtained from readily available pricing sources.  Level 2 – Valuation is based on observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.  Level 3 – Valuation is based on unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using unobservable inputs to pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.  In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment.  There were no assets or liabilities measured at fair value at December 31, 2019. At December 31, 2018, assets held for sale is the only item in the financial statements measured at fair value. Assets held for sale are considered level 3. The fair value of assets held for sale was determined using the sales price per the amended purchase and sale agreement, less the estimated cost to sell (see Note 5).  Long-lived and intangible assets  The Company assesses the impairment of long-lived assets and intangible assets with finite lives annually or whenever events or changes in circumstances indicate that the carrying value may not be fully recoverable. Based upon the review, the Company did not record any impairment charges in 2019 or 2018.  Intangible assets consist of the following at:      Estimated December 31, 2019 December 31, 2018  Useful Life Accumulated Accumulated  (in years) Gross Amortization Net Gross Amortization Net  Patents and trademarks 10 $ 36,880 15,382 $ 21,498 $ 36,880 $ 12,134 $ 24,746  Patents and trademarks pending — 2,143 — 2,143 2,143 — 2,143  Trade names 15 29,398 5,530 23,868 29,398 3,132 26,266  Total intangible assets $ 68,421 $ 20,912 $ 47,509 $ 68,421 $ 15,266 $ 53,155  Amortization expense related to intangible assets was $5,646 and $4,639 in 2019 and 2018 , respectively. Estimated future annual amortization expense for currently amortized intangible assets is expected to range from approximately $5,600 annually, declining to approximately $2,600 annually, through the year 2033.  Income taxes  The Company recognizes deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between the financial statement and tax bases of assets and liabilities using tax rates in effect for the year in which the differences are expected to reverse.  The Company follows the provisions of FASB ASC 740, “Accounting for Income Taxes”, which provides detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Tax positions must meet a “more-likely-than-not” recognition threshold at the effective date to be recognized. No interest and penalties related to uncertain tax positions were incurred during 2019 and 2018. The Company’s primary operations are located in the United States. Tax years ended December 31, 2016 or later remain subject to examination by the IRS and state taxing authorities.  Share-based compensation  Share-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the employee’s requisite service period (generally the vesting period of the share-based grant).  Earnings per share data  Basic earnings (loss) per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding. The computation of diluted earnings (loss) per share is similar to the computation of basic earnings (loss) per share except that the denominator is increased to include the average number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued. In addition, the numerator is adjusted for any changes in net income (loss) that would result from the assumed conversions of those potential shares.  Research and development  Research and development expenses include costs directly attributable to conducting research and development programs primarily related to the development of a unique process to improve silver coating during the manufacturing processes, including the design and testing of specific process improvements for certain medical device components. Such costs include salaries, payroll taxes, employee benefit costs, materials, supplies, depreciation on research equipment, and services provided by outside contractors. All costs associated with research and development programs are expensed as incurred.  Recently issued accounting pronouncements  In the normal course of business, management evaluates all new accounting pronouncements issued by the FASB to determine the potential impact they may have on the Company’s Consolidated Financial Statements. Based upon this review, management does not expect any of the recently issued accounting pronouncements, which have not already been adopted, to have a material impact on the Company’s consolidated financial statements.  In February 2016, the FASB issued ASU 2016-02, “Leases,” which requires a lessee to recognize lease liabilities for the lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis, and right-of-use assets, representing the lessee’s right to use, or to control the use of, specified assets for the lease term. The Company adopted the ASU on January 1, 2019 and, based on its current portfolio of leases (which consists solely of office equipment leases), no lease assets or liabilities have been recognized in these financial statements.  On August 29, 2018, the FASB issued ASU 2018-15, to address a customer’s accounting for implementation costs incurred in a cloud computing arrangement (CCA) hosted by the vendor - that is a service contract. The Company adopted the ASU on January 1, 2019. ASU 2018-15 aligns the accounting for costs incurred to implement a CCA that is a service arrangement with the guidance on capitalizing costs associated with obtaining internal-use software. Specifically, implementation and development costs, including those for CCAs that do not transfer a software license, may qualify for capitalization based on the phase and nature of the costs. During 2019, the Company initiated a cloud-based software implementation. As of December 31, 2019, the company capitalized $4,331 (the first costs of implementation), which will be expensed over the remaining life of the service agreement upon completion.  Management does not expect any recently issued, but not yet effective, accounting standards to have a material effect on its results of operations or financial conditions.  Reclassification of prior period balances  Amounts in prior year financial statements are reclassified when necessary to conform to the current year presentation.

Inventories

Inventories	12 Months Ended
	Dec. 31, 2019
Inventories [Abstract]
Inventories	3. Inventories  Inventories consist of the following:      December 31, December 31,  2019 2018  Raw materials $ 923,502 $ 1,079,887  Work-in-process 393,433 1,105,272  Finished goods 1,151,713 1,499,900  Total $ 2,468,648 $ 3,685,059  The total cost of silver in inventory as raw materials, as work-in-process or as a plated surface on finished goods had an estimated cost of $380,347 and $461,272 at December 31, 2019 and 2018 , respectively.

Property, Plant and Equipment,

Property, Plant and Equipment, Net	12 Months Ended
	Dec. 31, 2019
Property, Plant and Equipment, net [Abstract]
Property, Plant and Equipment, net	4. Property, Plant and Equipment, Net  Property, plant and equipment, net consist of the following:      Asset Lives December 31, December 31,  (in years) 2019 2018  Machinery and equipment 3 to 15 $ 18,129,460 $ 17,978,781  Building and improvements 5 to 25 3,991,951 3,991,951  Vehicles 3 to 5 100,096 98,119  Furniture, fixtures, computers and software 3 to 5 1,470,102 1,440,071  Construction in progress 25,207 168,094  Total property, plant and equipment 23,716,816 23,677,016  Less: accumulated depreciation (19,914,900) (18,545,243)  Property, plant and equipment, net $ 3,801,916 $ 5,131,773  For the year ended December 31, 2019 , the Company recorded $1,457,797 of depreciation expense compared to $1,499,398 for the year ended December 31, 2018 . There are no commitments related to the completion of construction in process as of December 31, 2019 .

Assets Held For Sale

Assets Held For Sale	12 Months Ended
	Dec. 31, 2019
Assets Held For Sale [Abstract]
Assets Held For Sale	5. Assets Held for Sale  In January 2016, the Company entered into a Purchase and Sale Agreement with a buyer to sell two unoccupied buildings, with a total of approximately 52,000 square feet, and land. As a result, the Company classified the property as Assets Held for Sale with a carrying value of $688,750, which approximated the fair value less the expected cost to sell.  On August 6, 2019, the Company closed on the sale of the property and received proceeds of $663,334 which is net of selling costs incurred. 

Debt

Debt	12 Months Ended
	Dec. 31, 2019
Debt [Abstract]
Debt	6. Debt  The following table sets forth the items which comprise debt for the Company:       December 31, December 31,  2019 2018  Revolving line of credit $ 1,274,299 $ 2,025,592   Total term notes payable, net of issuance costs $ 3,557,458 $ 3,946,878  Less current portion, net 3,557,458 389,420  Term notes payable, non-current, net — 3,557,458   Subordinated notes payable, non-current, net 470,152 —  Total long term debt, net 3,636,819 3,557,458   Total short and long term debt, net $ 5,301,909 $ 5,972,470  Bank Debt  On December 29, 2017, the Company entered into a three -year $9,500,000 Credit and Security Agreement (the “credit agreement”) with a Massachusetts trust company, replacing the credit facility and forbearance agreement with the Company’s previous lender. The credit agreement also provided funds with which to discharge existing subordinated promissory notes.  The credit agreement includes a revolving line of credit of up to $5.0 million (“Revolver”), a machinery and equipment term note of $2.5 million (“Equipment Loan”) and a real estate term note of $2.0 million (“Real Estate Loan” and together with the “Equipment Loan” the “Term Loans”).  Revolver  The Revolver allows for interest only payments during the term of the facility with the full principal outstanding balance to be paid upon maturity on December 29, 2020 . Interest on all borrowings from the Revolver shall be equal to the Wall Street Journal prime rate (“Prime Rate”) plus 0.5%. In lieu of having interest charged at the Prime Rate, the Company shall have the option, on the last day of each month, (the “LIBOR Option”) to have interest charged at a rate of interest equal to the daily one-month LIBOR plus 3.25% for the following month. The interest rate will automatically convert back to the Prime Rate at the beginning of the next month unless the Company elects the LIBOR Option for the next month. The interest rate was 4.94% and 5.59% at December 31, 2019 and at December 31, 2018, respectively.  The Revolver carries a provision for a quarterly unused facility fee equal to 0.25% per annum of the average daily undisbursed face amount of the Revolver during the three months immediately preceding the applicable due date and has no prepayment penalty. The credit agreement provides for a daily sweep of cash balances against the balance of the Revolver. Availability to borrow under the Revolver is based on conditions defined in the credit agreement and amounts to approximately $810,000 at December 31, 2019.  Term Loans  The Equipment Loan requires monthly principal payments of approximately $29,762 , payable on the first day of each month commencing February 1, 2018. The Equipment Loan is based upon an 84 month amortization with a balloon payment of approximately $1,458,333 due and payable in full upon maturity on December 29, 2020 .  The Real Estate Loan requires monthly principal payments of approximately $8,333 , payable on the first day of each month commencing February 1, 2018. The Real Estate Loan is based upon a 240 month amortization with a balloon payment of approximately $1,708,333 due and payable in full upon maturity on December 29, 2020 .  Interest on the Term Loans shall be at such Wall Street Journal prime rate plus 0.75%. In lieu of having interest charged at the Prime Rate, the Company shall have a LIBOR Option, as described above, to have interest charged at a rate of interest equal to the daily one-month LIBOR plus 3.5% for the following month. The interest rate was 5.19% and 5.84% at December 31, 2019 and at December 31, 2018, respectively.  All interest will be calculated based upon a year of 360 days for actual days elapsed. All interest will accrue from the Closing Date and will be payable monthly in arrears. Upon the occurrence and during the continuation of an Event of Default, all interest will be increased by 2% above the per annum rate otherwise applicable thereto. The Term Loans carry a prepayment penalty with respect to the prepayment of any portion of either Term Loan.  This credit agreement contains covenants related to various matters including certain financial covenants, prohibitions on further borrowings and security interests, merger or consolidation, acquisitions, guarantees, sales of assets other than in the normal course of business, leasing, and payment of dividends. The lender has a security interest in all assets and a mortgage encumbering certain real property.  On March 7, 2019, the Company entered into the First Amendment to the Credit and Security Agreement in which the quarterly debt service coverage ratio measurement requirements for 2019 were amended. On August 6, 2019 the Company entered into the Second Amendment to the Credit and Security Agreement which consented to the sale of property (see Note 5) and to private placement loans in the form of subordinated promissory notes (see below). On August 19, 2019 the Company entered into the Third Amendment to the Credit and Security Agreement in which the debt service coverage ratio requirements for Q219 and Q319 were removed. On March 12, 2020 the Company entered into the Fourth Amendment to the Credit and Security Agreement in which the debt service coverage ratio requirement for Q419 was removed, the debt service coverage ratio for the first three quarters of 2020 was amended, and any noncompliance with the debt service coverage ratio for Q419 was waived.  Other debt  Subordinated promissory notes  In June 2019, the Company initiated a private offering to raise up to $500,000 through the sale of subordinated promissory notes (the “Notes”). The subscription for $500,000 was completed on July 5, 2019. The Notes bear interest on the unpaid principal at a simple annual interest rate equal to 10% per annum from the date of issuance. Interest only is payable in cash on a quarterly basis. The Notes mature on July 5, 2022. Each investor entered into a Subordination Agreement providing that the indebtedness pursuant to the Notes shall be subordinated to all indebtedness of the Company pursuant to its existing credit agreement .  F or every $50,000 in principal invested in the notes, each investor received a warrant to purchase 10,000 shares of common stock (collectively, the “Warrants”, see Note 10). The Warrants are exercisable at an exercise price equal to $2.90 per share, namely, the average closing market price of the Company’s common stock on the fifteen days prior to the date of the Warrant, plus 12% . The Warrants contain standard provisions relating to anti-dilution adjustments for stock splits and recapitalizations. The Warrants also provide the investors with standard piggy-back registration rights in the event the Company files a registration statement (other than a registration statement on Form S-4 or S-8) to register the shares of common stock subject to standard limitations in the discretion of any underwriter.  In order to account for the subordinated notes payable and warrants, the Company allocated the proceeds between the notes and warrants on a relative fair value basis. As a result, the Company allocated $464,182 to the notes and $35,818 to the warrants. The total discount on the notes is being recognized as non-cash interest expense over the term of the notes. As of December 31, 2019, there was $5,970 in non-cash interest expense recorded related to the amortization of the discount.  Related parties participated in the private offering as follows:    Jason Chambers, Director $ 50,000  Rodd Friedman, Director $ 100,000  Andrei Soran. Director $ 50,000  Future maturities of term debt  Future maturities of term debt for the years ending December 31 are as follows:      2020 2021 2022 2023 2024 Thereafter Total  Term loans 3,623,809 — — — — — 3,623,809  Subordinated promissory notes — — 500,000 — — — 500,000

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2019
Income Taxes [Abstract]
Income Taxes	7. Income Taxes  The income tax provision consists of the following:      Year Ended  December 31,  2019 2018  Current:  Federal $ — $ —  State — 2,168  Total current income taxes — 2,168  Deferred:  Federal — —  State — —  Total deferred income taxes — —  Total income tax provision $ — $ 2,168  The components of deferred income taxes are as follows:      Year Ended  December 31,  2019 2018  Deferred tax assets:   Net operating loss carryforwards $ 3,541,500 $ 3,144,600  Federal and state tax credit carryforwards 476,100 525,000  Accruals and reserves 150,800 104,400  Stock based compensation 106,400 68,300  Patents and intangibles 5,000 12,000  Other long-term 5,400 45,300  Total long-term deferred tax assets 4,285,200 3,899,600   Deferred tax valuation allowance (3,877,700) (3,374,800)  Deferred tax assets, net of allowance 407,500 524,800   Property, plant and equipment (379,900) (478,200)  Prepaid expenses (24,500) (43,500)  Total deferred tax liabilities (404,400) (521,700)   Net deferred tax assets $ 3,100 $ 3,100  In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax-planning strategies in making this ass essment. As of December 31, 2019 , the Company continues to maintain a valuation allowance against all of its domestic and foreign deferred tax assets, except for its AMT Credit carryforward, which is treated as a refundable attribute under the new tax law.  For the year ended December 31, 2019, the Company has federal and state net operating loss carryforwards totaling $12,988,000 and $12,885,000 , respectively, which begin to expire in 2031. The Company also had federal and state tax credit carryovers of $306,000 and $219,000 , respectively. The federal and state credits begin to expire in 2027 and 2020, respectively.  The Company files a consolidated federal income tax return. The actual income tax provision differs from applying the Federal statutory income tax rate ( 21% ) to the pre-income tax loss from continuing operations as follows:     Year Ended  December 31,  2019 2018  Tax benefit computed at statutory rate $ (481,139) $ (216,791)  Increases (reductions) due to:  Change in valuation allowance 502,900 202,700  State income taxes, net of federal benefit (19,580) 1,713  Permanent differences 12,348 9,669  Tax credits (federal and state) — (7,326)  Differences on prior returns (federal and state) (14,529) 12,203  Income tax provision $ — $ 2,168

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
	Dec. 31, 2019
Employee Benefit Plans [Abstract]
Employee Benefit Plans	8. Employee Benefit Plans  The Company sponsors an Employee Savings and Investment Plan under Section 401(k) of the Internal Revenue Code covering all eligible employees of the Company. Employees can contribute up to 90% of their eligible compensation to the maximum allowable by the IRS. The Company’s matching contributions are at the discretion of the Company. The Company’s matching contributions in 2019 and 2018 were $40,477 and $39,039 , respectively.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2019
Commitments and Contingencies [Abstract]
Commitments and Contingencies	9. Commitments and Contingencies  Legal matters  In the ordinary course of its business, the Company is involved in various legal proceedings involving a variety of matters. The Company does not believe there are any pending legal proceedings that will have a material impact on the Company’s financial position or results of operations.  Operating lease agreements  No lease assets or liabilities have been recognized under ASC 842 in these financial statements as management has determined the individual leases to be immaterial. Lease expense under all operating leases was $20,613 and $24,033 for the years ended December 31, 2019 and 2018, respectively. Future minimum lease payments for the years ending December 31 are as follows:    2020 $ 18,851  2021 $ 10,996 

Shareholders' Equity

Shareholders' Equity	12 Months Ended
	Dec. 31, 2019
Shareholders' Equity [Abstract]
Shareholders' Equity	10 . Shareholders’ equity  Common stock  In 2019 and 2018, the Company issued 22,181 and 21,734 shares of the Company’s common stock from treasury, pursuant to the 2010 Equity Incentive Plan, with a fair value of $55,791 and $75,750 , respectively, for directors’ fees in lieu of cash payments. In 2019, the Company issued 23,420 shares of the Company’s common stock from Treasury, pursuant to the 2019 Equity Incentive Plan with a fair value of $54,750 for directors’ fees in lieu of cash payments.  No shares were issued as a result of the exercise of stock options or the exercise of warrants in 2019 or 2018.  No dividends were declared or paid in 2019 or 2018.  Warrants  No warrants were exercised in 2019 or 2018. 70,000 warrants expired on December 31, 2018.  On June 28, 2019, 90,000 warrants were issued with an exercise price of $2.90 in conjunction with the Company’s subordinated notes payable offering. On July 5, 2019, 10,000 warrants were issued with an exercise price of $2.90. The warrants are exercisable upon issuance for three years and expire in July 2022.  Stock options and Share-based incentive plans  Equity Incentive Plans  In March 2010, the Company's Board of Directors adopted the Micron Solutions, Inc. 2010 Equity Incentive Plan (the “2010 Plan”). The 2010 Plan authorizes the issuance of an aggregate of 500,000 shares. The Plan provides the Company flexibility to award a mix of stock options, equity incentive grants, performance awards and other types of stock-based compensation to certain eligible employees, non-employee directors, or consultants. An aggregate of 500,000 shares were reserved for such grants. The options granted have ten year contractual terms that vest annually between three to five -year terms.  At December 31, 2019, there were options to acquire an aggregate of 293,665 shares outstanding under the 2010 Plan.  On March 25, 2019, the Company’s Board of Directors adopted the 2019 Equity Incentive Plan (the “2019 Plan”) which was approved by the stockholders at the May 23, 2019 Annual Meeting. The 2019 Plan authorizes the issuance of an aggregate of 500,000 shares. All non-issued shares of the 2010 Equity Incentive Plan expired upon the adoption of the 2019 Plan. The 2019 Plan provides the Company flexibility to award a mix of stock options, equity incentive grants, performance awards and other types of stock-based compensation. The options granted have five year contractual terms for grants issued to greater than 10% stockholders and ten year contractual terms for less than 10% stockholders.  At December 31, 2019, there were options to acquire an aggregate of 37,500 shares outstanding under the 2019 Plan.  The fair value of each stock option award is estimated on the date of grant using the Black-Scholes option pricing model that uses the assumptions noted in the following table. Expected volatilities are based on historical volatility of the common stock using historical periods consistent with the expected term of the options. The expected term of options granted under the Company’s equity incentive plan, all of which qualify as “plain vanilla,” is based on the average of the contractual term and the vesting period as permitted under SEC Staff Accounting Bulletin Nos. 107 and 110. The risk-free rate is based on the yield of a U.S. Treasury security with a term consistent with the option. During 2019, there were 7,500 new option grants under the 2010 Equity Incentive Plan and 37,500 new option grants under the 2019 Equity Incentive Plan. During 2018, there were 195,000 new option grants under the 2010 Equity Incentive Plan. The assumptions used to measure the fair value of option grants in 2019 and 2018 were as follows:      Year Ended  December 31,  2019 2018  Expected option term 5.5 to 6.0 5.5 to 6.25  Expected volatility factor 53.42% 16.96% to 26.87%  Risk-free rate 1.52% to 2.51% 2.36% to 2.94%  Expected annual dividend yield - -  The following table sets forth stock option activity for the year ended December 31, 2019:      Weighted  Weighted average  Average remaining Aggregate  Number of Exercise contractual Intrinsic  options Price term (in years) Value  Outstanding at December 31, 2018 393,500 $ 4.89 7.22 $ 960  Granted 45,000 2.50  Forfeited (51,671) 4.04  Expired (55,664) 5.68  Outstanding at December 31, 2019 331,165 $ 4.57 6.63 $ 1,050  Exercisable at December 31, 2019 179,824 $ 5.62 4.75 $ 1,050  Exercisable at December 31, 2018 182,164 $ 6.09 4.81 $ 960  During 2019, the Company issued 15,000 restricted stock units with a fair value of $3.20 per share which vest on the one year anniversary of the grant.  The following table sets forth restricted stock unit activity for the year ended December 31, 2019:     Weighted  Average  Number of Grant Date  options Fair Value  Outstanding at December 31, 2018 — $ —  Granted 21,667 2.58  Exercised — —  Forfeited (6,667) 2.25  Expired — —  Outstanding at December 31, 2019 15,000 $ 3.20  Exercisable at December 31, 2019 — $ —  Exercisable at December 31, 2018 — $ —  For the years ended December 31, 2019 and 2018 , share-based compensation expense related to stock options and the non-cash issuance of common stock amounted to $70,133 and $56,168 , respectively. For the year ended December 31, 2019 share-based compensation expense related to restricted stock units amounted to $38,583 . Share-based compensation is included in general and administrati ve expenses. As of December 31, 2 019 there was $166,820 of un recognized compensation costs related to non-vested share-based compensation arrangements granted under the stock option plans. This cost is expected to be recognized over a weighted average period of 2.59 years for stock option and .2 years for restricted stock units. The weighted average grant date fair value of grants made in 2019 was $0.44 for stock options a nd $3.20 for restricted stock units.  At December 31, 2019 there were 439,080 shares available for future grants under the 2019 Plan after giving effect to shares which became available for reissuance due to expired or forfeited options.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2019
Subsequent Events [Abstract]
Subsequent Events	11. Subsequent Events  Amendment to the Credit and Security Agreement In March 2020, the Company executed the Fourth Amendment to its Credit and Security Agreement (see Note 1).  NYSE American Voluntary D elisting On March 16, 2020, the Company notified the NYSE American of its intent to delist from the NYSE American. O n March 26 , 2020, the Company filed a Form 25 with the SEC notifying them of the Company’s delisting from the NYSE American, which is expected to take place on or about April 6. 2020.

Accounting Policies (Policies)

Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Principles of consolidation	Principles of consolidation  The consolidated financial statements (the "financial statements") include the accounts of Micron Solutions, Inc. and its operating subsidiary, Micron Products, Inc. All intercompany balances and transactions have been eliminated in consolidation.
Use of estimates	Use of estimates  The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.
Revenue Recognition	Revenue recognition  The Company adopted ASU No. 2014-09, “Revenue from Contracts with Customers, Topic 606” (“Topic 606”) effective January 1, 2018 using the modified retrospective approach. Under the modified retrospective method, a cumulative effect of initially applying the new standard is recorded as an adjustment to the opening balance of retained earnings at the date of initial application. By electing to use this method, there is no restatement of the comparative periods presented (i.e., interim periods and fiscal year ending 2017). As permitted by Topic 606 transition guidance (outlined below), the Company has elected to apply the new standard only to contracts that were not completed contracts at the date of initial application, and therefore, the Company only evaluated those contracts that were in-process and not completed before January 1, 2018.  The Company determined that customer purchase orders represent contracts with a customer. For each contract, the Company considers the promise to transfer products, each of which are distinct, to be the identified performance obligations.  Shipping and handling activities for which the Company is responsible are not a separate promised service but instead are activities to fulfill the entity’s promise to transfer goods. Shipping and handling fees will be recognized at the same time as the related performance obligations are satisfied.  The Company determines the transaction price as the amount of consideration it expects to receive in exchange for transferring promised goods or services to the customer. If a contract includes a variable amount, such as a rebate, then the Company estimates the transaction price using either the expected value or the most likely amount of consideration to be received, depending upon the specific facts and circumstances. The Company includes estimated variable consideration in the transaction price only to the extent it is probable that a significant reversal of revenue will not occur when the uncertainty is resolved. The Company updates its estimate of variable consideration at the end of each reporting period to reflect changes in facts and circumstances.  The Company recognizes revenue at the point in time when it transfers control of the promised goods or services to the customer, which typically occurs once the product has shipped or has been delivered to the customer. For certain customer warehousing agreements, delivery is deemed to have occurred when the customer pulls inventory out of the warehouse for use in their production. Additionally, for certain customers, delivery is deemed to have occurred when items are delivered to bill and hold locations at the Company’s facility.  The Company evaluated the nature of any guarantees or warranties related to its contracts with customers. The Company provides an assurance-type warranty that only covers the products’ compliance with agreed-upon specifications and does not provide the customer with a service in addition to the assurance that the product complies with agreed-upon specifications.  Certain contracts contain prepayment terms that result in liabilities for customer deposits. Additionally, certain contracts provide for invoicing before all performance obligations have been fulfilled which results in deferred revenue. Customer deposits and advance invoicing are recorded as contract liabilities on the Company’s consolidated balance sheet.  The Company generally expenses sales commission when incurred because the amortization period would have been one year or less. These costs are recorded within selling and marketing expenses.  The Company does not disclose the value of unsatisfied performance obligations for contracts with an original expected duration of one year or less.  The implementation of Topic 606 affects the timing of certain revenue related transactions primarily resulting from the earlier recognition of the Company's tooling revenue and costs. Under legacy GAAP, the Company accounted for tooling as multiple element arrangements whereby revenue and cost were recognized over a period of time after the tool was completed. Upon adoption of ASU 2014-09, tooling sales and costs are now recognized at the point in time upon which the tool is complete and the Company has satisfied all its performance obligations under the contract.  As a result of the initial application of Topic 606 in 2018, the Company made an adjustment to its beginning accumulated deficit of ( $13,991 ) to recognize the remaining deferred revenue ( $18,333 ) and deferred costs ( $32,324 ) recorded as of December 31, 2017 relative to certain completed tooling sales.  During the twelve months ended December 31, 2019, the Company recognized as revenue $5 49,326 of amounts recorded as Contract Liabilities at December 31, 2018. During the twelve months ended December 31, 2018, the Company recognized as revenue $85,833 of amounts recorded as Contract Liabilities at December 31, 2017.
Fair value of financial instruments	Fair value of financial instruments  The carrying amount reported in the balance sheets for cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair value due to the immediate or short-term nature of such instruments. The carrying value of debt approximates fair value since it provides for market terms and interest rates.
Concentration of credit risk	Concentration of credit risk  Financial instruments which potentially expose the Company to concentrations of credit risk consist primarily of accounts receivable and cash and cash equivalents. It is the Company’s policy to place its cash in high quality financial institutions. The Company does not believe significant credit risk exists above federally insured limits with respect to these institutions.  Accounts receivable are customer obligations due under normal trade terms. A large portion of the Company's products are sold to large diversified medical, military and automotive parts product manufacturers. The Company does not generally require collateral for its sales; however, the Company believes that its terms of sale provide adequate protection against credit risk.  During the year ended December 31, 2019 , the Company had net sales to two customers constituting 18% and 10% of total net sales. Accounts receivable from these two customers at December 31, 2019 was 16% and 9% , respectively, of the total accounts receivable balance at year end. During the year ended December 31, 2018 , the Company had net sales to three customers constituting 18%, 12% and 10% , respectively, of total net sales. Accounts receivable from these three customers at December 31, 2018 was 20%, 7% and 7% , respectively, of the total accounts receivable balance at year end.  The Company competes globally, with 37% of its revenue derived from exports in 2019. While some risks exist in foreign markets, the Company’s customers have historically been based in stable regions. The Company has agreements with certain foreign customers to hold inventory at customer locations where title and control transfers and revenue is recognized when the product is consumed by the customer. Accounts receivable insurance is used where available and appropriate to reduce risk in these markets. 
Cash and cash equivalents	Cash and cash equivalents  The Company considers all highly liquid investments with an original maturity of three months or less at the date of purchase to be cash equivalents. Cash and cash equivalents consist of cash on hand in high quality financial institutions The Company’s credit agreement provides for a daily sweep of cash balances against the balance of the Revolver (see Note 6).
Accounts receivable and allowance for doubtful accounts	Accounts receivable and allowance for doubtful accounts  Accounts receivable represent amounts invoiced by the Company. Management maintains an allowance for doubtful accounts based on information obtained regarding individual accounts and historical experience. Amounts deemed uncollectible are written off against the allowance for doubtful accounts.
Inventories	Inventories  The Company values its inventory at the lower of average cost, or net realizable value, and cost is determined using first in first out (FIFO) or, for sensors, using average cost. The Company reviews its inventory for quantities in excess of production requirements, for obsolescence and for compliance with internal quality specifications. A review of inventory on hand is made at least annually and obsolete inventory may be disposed of and/or recycled. Any adjustments to inventory would be equal to the difference between the cost of inventory and the estimated net realizable value based upon assumptions about future demand, market conditions and expected cost to distribute those products to market. The Company also has supply agreements with certain foreign customers to hold inventory at the customer’s warehouses. 
Property, plant and equipment	Property, plant and equipment  Property, plant and equipment are recorded at cost and include expenditures which substantially extend their useful lives. Depreciation on property, plant and equipment is calculated using the straight-line method over the estimated useful lives of the assets. Expenditures for maintenance and repairs are charged to earnings as incurred. When equipment is retired or sold, the resulting gain or loss is reflected in earnings.
Fair value heirarchy	Fair value hierarchy  The Company groups its assets and liabilities measured at fair value in three levels, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value.  Level 1 – Valuation is based on quoted prices in active markets for identical assets or liabilities. Valuations are obtained from readily available pricing sources.  Level 2 – Valuation is based on observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.  Level 3 – Valuation is based on unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using unobservable inputs to pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.  In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment.  There were no assets or liabilities measured at fair value at December 31, 2019. At December 31, 2018, assets held for sale is the only item in the financial statements measured at fair value. Assets held for sale are considered level 3. The fair value of assets held for sale was determined using the sales price per the amended purchase and sale agreement, less the estimated cost to sell (see Note 5).
Long-lived and intangible assets	Long-lived and intangible assets  The Company assesses the impairment of long-lived assets and intangible assets with finite lives annually or whenever events or changes in circumstances indicate that the carrying value may not be fully recoverable. Based upon the review, the Company did not record any impairment charges in 2019 or 2018.  Intangible assets consist of the following at:      Estimated December 31, 2019 December 31, 2018  Useful Life Accumulated Accumulated  (in years) Gross Amortization Net Gross Amortization Net  Patents and trademarks 10 $ 36,880 15,382 $ 21,498 $ 36,880 $ 12,134 $ 24,746  Patents and trademarks pending — 2,143 — 2,143 2,143 — 2,143  Trade names 15 29,398 5,530 23,868 29,398 3,132 26,266  Total intangible assets $ 68,421 $ 20,912 $ 47,509 $ 68,421 $ 15,266 $ 53,155  Amortization expense related to intangible assets was $5,646 and $4,639 in 2019 and 2018 , respectively. Estimated future annual amortization expense for currently amortized intangible assets is expected to range from approximately $5,600 annually, declining to approximately $2,600 annually, through the year 2033.
Income taxes	Income taxes  The Company recognizes deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between the financial statement and tax bases of assets and liabilities using tax rates in effect for the year in which the differences are expected to reverse.  The Company follows the provisions of FASB ASC 740, “Accounting for Income Taxes”, which provides detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Tax positions must meet a “more-likely-than-not” recognition threshold at the effective date to be recognized. No interest and penalties related to uncertain tax positions were incurred during 2019 and 2018. The Company’s primary operations are located in the United States. Tax years ended December 31, 2016 or later remain subject to examination by the IRS and state taxing authorities.
Share-based compensation	Share-based compensation  Share-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the employee’s requisite service period (generally the vesting period of the share-based grant).
Earnings per share data	Earnings per share data  Basic earnings (loss) per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding. The computation of diluted earnings (loss) per share is similar to the computation of basic earnings (loss) per share except that the denominator is increased to include the average number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued. In addition, the numerator is adjusted for any changes in net income (loss) that would result from the assumed conversions of those potential shares.
Research and development	Research and development  Research and development expenses include costs directly attributable to conducting research and development programs primarily related to the development of a unique process to improve silver coating during the manufacturing processes, including the design and testing of specific process improvements for certain medical device components. Such costs include salaries, payroll taxes, employee benefit costs, materials, supplies, depreciation on research equipment, and services provided by outside contractors. All costs associated with research and development programs are expensed as incurred.
Recently Issued Accounting Pronouncements	Recently issued accounting pronouncements  In the normal course of business, management evaluates all new accounting pronouncements issued by the FASB to determine the potential impact they may have on the Company’s Consolidated Financial Statements. Based upon this review, management does not expect any of the recently issued accounting pronouncements, which have not already been adopted, to have a material impact on the Company’s consolidated financial statements.  In February 2016, the FASB issued ASU 2016-02, “Leases,” which requires a lessee to recognize lease liabilities for the lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis, and right-of-use assets, representing the lessee’s right to use, or to control the use of, specified assets for the lease term. The Company adopted the ASU on January 1, 2019 and, based on its current portfolio of leases (which consists solely of office equipment leases), no lease assets or liabilities have been recognized in these financial statements.  On August 29, 2018, the FASB issued ASU 2018-15, to address a customer’s accounting for implementation costs incurred in a cloud computing arrangement (CCA) hosted by the vendor - that is a service contract. The Company adopted the ASU on January 1, 2019. ASU 2018-15 aligns the accounting for costs incurred to implement a CCA that is a service arrangement with the guidance on capitalizing costs associated with obtaining internal-use software. Specifically, implementation and development costs, including those for CCAs that do not transfer a software license, may qualify for capitalization based on the phase and nature of the costs. During 2019, the Company initiated a cloud-based software implementation. As of December 31, 2019, the company capitalized $4,331 (the first costs of implementation), which will be expensed over the remaining life of the service agreement upon completion.  Management does not expect any recently issued, but not yet effective, accounting standards to have a material effect on its results of operations or financial conditions. 
Reclassification of prior period balances	Reclassification of prior period balances  Amounts in prior year financial statements are reclassified when necessary to conform to the current year presentation.

Accounting Policies (Tables)

Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Schedule Of Intangible Assets	   Estimated December 31, 2019 December 31, 2018  Useful Life Accumulated Accumulated  (in years) Gross Amortization Net Gross Amortization Net  Patents and trademarks 10 $ 36,880 15,382 $ 21,498 $ 36,880 $ 12,134 $ 24,746  Patents and trademarks pending — 2,143 — 2,143 2,143 — 2,143  Trade names 15 29,398 5,530 23,868 29,398 3,132 26,266  Total intangible assets $ 68,421 $ 20,912 $ 47,509 $ 68,421 $ 15,266 $ 53,155 

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2019
Inventories [Abstract]
Schedule Of Inventories	   December 31, December 31,  2019 2018  Raw materials $ 923,502 $ 1,079,887  Work-in-process 393,433 1,105,272  Finished goods 1,151,713 1,499,900  Total $ 2,468,648 $ 3,685,059 

Property, Plant and Equipment_2

Property, Plant and Equipment, net (Tables)	12 Months Ended
	Dec. 31, 2019
Property, Plant and Equipment, net [Abstract]
Property, Plant and Equipment, net	   Asset Lives December 31, December 31,  (in years) 2019 2018  Machinery and equipment 3 to 15 $ 18,129,460 $ 17,978,781  Building and improvements 5 to 25 3,991,951 3,991,951  Vehicles 3 to 5 100,096 98,119  Furniture, fixtures, computers and software 3 to 5 1,470,102 1,440,071  Construction in progress 25,207 168,094  Total property, plant and equipment 23,716,816 23,677,016  Less: accumulated depreciation (19,914,900) (18,545,243)  Property, plant and equipment, net $ 3,801,916 $ 5,131,773 

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2019
Debt [Abstract]
Summary of Debt	    December 31, December 31,  2019 2018  Revolving line of credit $ 1,274,299 $ 2,025,592   Total term notes payable, net of issuance costs $ 3,557,458 $ 3,946,878  Less current portion, net 3,557,458 389,420  Term notes payable, non-current, net — 3,557,458   Subordinated notes payable, non-current, net 470,152 —  Total long term debt, net 3,636,819 3,557,458   Total short and long term debt, net $ 5,301,909 $ 5,972,470 
Schedule Of Related Parties Private Offering	  Jason Chambers, Director $ 50,000  Rodd Friedman, Director $ 100,000  Andrei Soran. Director $ 50,000 
Future Maturities of Debt	   2020 2021 2022 2023 2024 Thereafter Total  Term loans 3,623,809 — — — — — 3,623,809  Subordinated promissory notes — — 500,000 — — — 500,000 

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2019
Income Taxes [Abstract]
Income Tax Provision	   Year Ended  December 31,  2019 2018  Current:  Federal $ — $ —  State — 2,168  Total current income taxes — 2,168  Deferred:  Federal — —  State — —  Total deferred income taxes — —  Total income tax provision $ — $ 2,168 
Deferred Income Taxes	   Year Ended  December 31,  2019 2018  Deferred tax assets:   Net operating loss carryforwards $ 3,541,500 $ 3,144,600  Federal and state tax credit carryforwards 476,100 525,000  Accruals and reserves 150,800 104,400  Stock based compensation 106,400 68,300  Patents and intangibles 5,000 12,000  Other long-term 5,400 45,300  Total long-term deferred tax assets 4,285,200 3,899,600   Deferred tax valuation allowance (3,877,700) (3,374,800)  Deferred tax assets, net of allowance 407,500 524,800   Property, plant and equipment (379,900) (478,200)  Prepaid expenses (24,500) (43,500)  Total deferred tax liabilities (404,400) (521,700)   Net deferred tax assets $ 3,100 $ 3,100 
Federal Income Taxes	   Year Ended  December 31,  2019 2018  Tax benefit computed at statutory rate $ (481,139) $ (216,791)  Increases (reductions) due to:  Change in valuation allowance 502,900 202,700  State income taxes, net of federal benefit (19,580) 1,713  Permanent differences 12,348 9,669  Tax credits (federal and state) — (7,326)  Differences on prior returns (federal and state) (14,529) 12,203  Income tax provision $ — $ 2,168 

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2019
Commitments and Contingencies [Abstract]
Schedule of Future Minimum Lease Payments	  2020 $ 18,851  2021 $ 10,996 

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2019
Shareholders' Equity [Abstract]
Fair Value of Option Grants	   Year Ended  December 31,  2019 2018  Expected option term 5.5 to 6.0 5.5 to 6.25  Expected volatility factor 53.42% 16.96% to 26.87%  Risk-free rate 1.52% to 2.51% 2.36% to 2.94%  Expected annual dividend yield - - 
Stock Option Transactions	   Weighted  Weighted average  Average remaining Aggregate  Number of Exercise contractual Intrinsic  options Price term (in years) Value  Outstanding at December 31, 2018 393,500 $ 4.89 7.22 $ 960  Granted 45,000 2.50  Forfeited (51,671) 4.04  Expired (55,664) 5.68  Outstanding at December 31, 2019 331,165 $ 4.57 6.63 $ 1,050  Exercisable at December 31, 2019 179,824 $ 5.62 4.75 $ 1,050  Exercisable at December 31, 2018 182,164 $ 6.09 4.81 $ 960 
RSU Activity	   Weighted  Average  Number of Grant Date  options Fair Value  Outstanding at December 31, 2018 — $ —  Granted 21,667 2.58  Exercised — —  Forfeited (6,667) 2.25  Expired — —  Outstanding at December 31, 2019 15,000 $ 3.20  Exercisable at December 31, 2019 — $ —  Exercisable at December 31, 2018 — $ — 

Description of Business (Narrat

Description of Business (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Description of Business [Abstract]
Percent of revenue derived from exports	37.00%
Cash and cash equivalents	$ 503	$ 1,715
Current borrowing capacity	810,000
Proceeds from subordinated debt	$ 500,000

Accounting Policies (Narrative)

Accounting Policies (Narrative) (Details)	12 Months Ended
	Dec. 31, 2019USD ($)customer	Dec. 31, 2018USD ($)customer	Dec. 31, 2017USD ($)
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Percent of revenue derived from exports	37.00%
Impairment of intangibles	$ 0
Amortization expense	5,646	$ 4,639
Contract liabilities, current portion	5,472	$ 560,802
Accounting Standards Update 2014-09 [Member] | Accumulated Deficit [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Adjustment due to adoption of accounting standard	(13,991)
Accounting Standards Update 2014-09 [Member] | Deferred Revenue [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Adjustment due to adoption of accounting standard	(18,333)
Accounting Standards Update 2014-09 [Member] | Deferred Costs [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Adjustment due to adoption of accounting standard	(32,324)
Maximum
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Estimated future amortization	5,600
Minimum
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Estimated future amortization	$ 2,600
Sales Revenue, Net [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Number of customers, concentration of credit risk | customer	2	3
Contract liabilities, current portion			$ 85,833
Sales Revenue, Net [Member] | Customer 1 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Concentration of credit risk, percentage	18.00%	12.00%
Sales Revenue, Net [Member] | Customer 2 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Concentration of credit risk, percentage		10.00%
Sales Revenue, Net [Member] | Customer 3 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Concentration of credit risk, percentage	10.00%
Accounts Receivable [Member] | Customer 1 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Concentration of credit risk, percentage	16.00%
Accounts Receivable [Member] | Two Customers [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Number of customers, concentration of credit risk | customer		3
Accounts Receivable [Member] | Customer 2 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Concentration of credit risk, percentage		7.00%
Accounts Receivable [Member] | Customer 3 [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Concentration of credit risk, percentage	9.00%
Accounts Receivable [Member] | Three Customers [Member]
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Number of customers, concentration of credit risk | customer	2

Accounting Policies (Schedule O

Accounting Policies (Schedule Of Intangible Assets) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Gross	$ 68,421	$ 68,421
Accumulated Amortization	20,912	15,266
Net	$ 47,509	53,155
Patents and Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (in years)	10 years
Gross	$ 36,880	36,880
Accumulated Amortization	15,382	12,134
Net	21,498	24,746
Patents and Trademarks Pending
Finite-Lived Intangible Assets [Line Items]
Gross	2,143	2,143
Net	$ 2,143	2,143
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (in years)	15 years
Gross	$ 29,398	29,398
Accumulated Amortization	5,530	3,132
Net	$ 23,868	$ 26,266

Change in Accounting Principle

Change in Accounting Principle (Narrative) (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Change in Accounting Principle [Abstract]
Accumulated deficit	$ (6,789,618)	$ (4,648,484)

Change in Accounting Principl_2

Change in Accounting Principle (Affected Lines From Legacy GAAP Treatment on Statement of Operations) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Change in Accounting Principle [Abstract]
Net sales	$ 17,499,364	$ 19,564,981
Cost of sales	15,737,469	17,241,289
Gross profit	1,761,895	2,323,692
Net income (loss) from operations	(1,715,416)	(757,580)
Net loss before income tax provision (benefit)	(2,141,134)	(1,096,139)
Net income (loss)	$ (2,141,134)	$ (1,098,307)
Earnings (loss) per share - basic and diluted	$ (0.74)	$ (0.39)
Weighted average common shares outstanding - basic and diluted	2,883,861	2,850,397

Change in Accounting Principl_3

Change in Accounting Principle (Affected Lines From Legacy GAAP Treatment on Balance Sheets) (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Change in Accounting Principle [Abstract]
Prepaid expenses and other current assets	$ 257,859	$ 389,390
Total current assets	4,879,264	7,090,718
Other assets	5,645	5,140
Total assets	8,734,334	12,280,786
Contract liabilities, current portion	5,472	560,802
Total current liabilities	6,062,133	4,635,220
Total long-term liabilities	470,152	3,557,458
Total liabilities	6,532,285	8,192,678
Accumulated deficit	(6,789,618)	(4,648,484)
Total shareholders’ equity	2,202,049	4,088,108	$ 5,068,488
Total liabilities and shareholders’ equity	$ 8,734,334	$ 12,280,786

Inventories (Narrative) (Detail

Inventories (Narrative) (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Inventories [Abstract]
Silver inventory	$ 380,347	$ 461,272

Inventories (Schedule Of Invent

Inventories (Schedule Of Inventories) (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Inventories [Abstract]
Raw materials	$ 923,502	$ 1,079,887
Work-in-process	393,433	1,105,272
Finished goods	1,151,713	1,499,900
Total	$ 2,468,648	$ 3,685,059

Property, Plant and Equipment_3

Property, Plant and Equipment, net (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Property, Plant and Equipment, net [Abstract]
Depreciation expense	$ 1,457,797	$ 1,499,398

Property, Plant and Equipment_4

Property, Plant and Equipment, net (Property, Plant and Equipment, net) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Property, Plant and Equipment
Total property, plant and equipment	$ 23,716,816	$ 23,677,016
Less: accumulated depreciation	(19,914,900)	(18,545,243)
Property, plant and equipment, net	3,801,916	5,131,773
Machinery and Equipment [Member]
Property, Plant and Equipment
Total property, plant and equipment	18,129,460	17,978,781
Building and improvements, maximum
Property, Plant and Equipment
Total property, plant and equipment	3,991,951	3,991,951
Vehicles, maximum
Property, Plant and Equipment
Total property, plant and equipment	100,096	98,119
Furniture, fixtures, computers and software, maximum
Property, Plant and Equipment
Total property, plant and equipment	1,470,102	1,440,071
Construction in Progress [Member]
Property, Plant and Equipment
Total property, plant and equipment	$ 25,207	$ 168,094
Maximum | Machinery and Equipment [Member]
Property, Plant and Equipment
Asset Lives (in years)	15 years
Maximum | Building and improvements, maximum
Property, Plant and Equipment
Asset Lives (in years)	25 years
Maximum | Vehicles, maximum
Property, Plant and Equipment
Asset Lives (in years)	5 years
Maximum | Furniture, fixtures, computers and software, maximum
Property, Plant and Equipment
Asset Lives (in years)	5 years
Minimum | Machinery and Equipment [Member]
Property, Plant and Equipment
Asset Lives (in years)	3 years
Minimum | Building and improvements, maximum
Property, Plant and Equipment
Asset Lives (in years)	5 years
Minimum | Vehicles, maximum
Property, Plant and Equipment
Asset Lives (in years)	3 years
Minimum | Furniture, fixtures, computers and software, maximum
Property, Plant and Equipment
Asset Lives (in years)	3 years

Assets Held For Sale (Narrative

Assets Held For Sale (Narrative) (Details)	1 Months Ended	12 Months Ended
	Jan. 31, 2016ft²item	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)
Assets Held For Sale [Abstract]
Number of unoccupied buildings with letter of intent to sale | item	2
Area of building | ft²	52,000
Assets held for sale, net		$ 0	$ 688,750
Proceeds from sale of property		$ 663,334	$ 0

Debt (Bank Debt Narrative) (Det

Debt (Bank Debt Narrative) (Details)	Dec. 29, 2017USD ($)item	Dec. 31, 2019USD ($)	Dec. 31, 2018
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Revolver, interest rate at end of period		4.94%	5.59%
Amount available under line of credit facility		$ 810,000
Revolving Credit Facility [Member] | Prime Rate [Member]
Debt Instrument [Line Items]
Spread on variable rate		0.50%
Revolving Credit Facility [Member] | LIBOR [Member]
Debt Instrument [Line Items]
Spread on variable rate		3.25%
Agreement [Member]
Debt Instrument [Line Items]
Debt instrument, face amount	$ 9,500,000
Debt maturity period		3 years
Agreement [Member] | Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Expiration Date		Dec. 29, 2020
Quarterly unused facility fee, percent		0.25%
Maximum borrowing capacity	5,000,000
Agreement - Equipment Loan [Member]
Debt Instrument [Line Items]
Debt instrument, face amount	$ 2,500,000
Number of months, amortization schedule | item	84
Debt instrument, balloon payment	$ 1,458,333
Agreement - Real Estate Loan [Member]
Debt Instrument [Line Items]
Number of months, amortization schedule | item	240
Debt instrument, balloon payment	$ 1,708,333
Agreement - Term Loans [Member]
Debt Instrument [Line Items]
Debt instrument, face amount	$ 2,000,000
Percent of increase in event of default	2.00%
Agreement - Term Loans [Member] | Prime Rate [Member]
Debt Instrument [Line Items]
Interest rate		5.19%	5.84%
Spread on variable rate	0.75%
Agreement - Term Loans [Member] | LIBOR [Member]
Debt Instrument [Line Items]
Spread on variable rate		3.50%

Debt (Other Debt Narrative) (De

Debt (Other Debt Narrative) (Details) - USD ($)	Dec. 29, 2017	Jun. 30, 2019	Dec. 31, 2019	Dec. 31, 2018	Jul. 05, 2019	Jun. 28, 2019
Debt Instruments [Line Items]
Private offering		$ 500,000
Proceeds from subordinated debt			$ 500,000
Payment on subordinated debt				$ 350,000
Warrants exercised			0
Warrants exercise price					$ 2.90	$ 2.90
Non-cash interest expense			$ 5,970
Subordinated promissory notes, exercise price of warrants					$ 2.90	$ 2.90
Warrants
Debt Instruments [Line Items]
Proceeds from subordinated debt			$ 35,818
Warrants exercised			0	0
Equipment Term Loans [Member]
Debt Instruments [Line Items]
Debt instrument, maturity date			Dec. 29, 2020
Per amount invested in notes	$ 29,762
Real Estate Term Loan [Member]
Debt Instruments [Line Items]
Debt instrument, maturity date			Dec. 29, 2020
Per amount invested in notes	8,333
Agreement [Member]
Debt Instruments [Line Items]
Debt instrument, face amount	$ 9,500,000
Private Offering [Member]
Debt Instruments [Line Items]
Debt instrument, interest rate			10.00%
Proceeds from subordinated debt			$ 464,182
Per amount invested in notes			$ 50,000
Private Offering [Member] | Warrants
Debt Instruments [Line Items]
Warrants to purchase outstanding			10,000
Warrants exercise price			$ 2.90
Percent of beneficial owner of company's common stock			12.00%
Subordinated promissory notes, exercise price of warrants			$ 2.90

Debt (Summary of Debt) (Details

Debt (Summary of Debt) (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Debt [Abstract]
Revolving line of credit	$ 1,274,299	$ 2,025,592
Total term notes payable, net of issuance costs	3,557,458	3,946,878
Less current portion, net	3,557,458	389,420
Term notes payable, non-current, net		3,557,458
Subordinated notes payable, non-current, net of discount	470,152	0
Total long term debt, net	3,636,819	3,557,458
Total short and long term debt, net	$ 5,301,909	$ 5,972,470

Debt (Schedule Of Related Parti

Debt (Schedule Of Related Parties Private Offering) (Details) - Private Placement [Member]	12 Months Ended
	Dec. 31, 2019USD ($)
Jason Chambers, Director [Member]
Subsidiary, Sale of Stock [Line Items]
Private offering	$ 50,000
Rodd Friedman, Director [Member]
Subsidiary, Sale of Stock [Line Items]
Private offering	100,000
Andrei Soran. Director [Member]
Subsidiary, Sale of Stock [Line Items]
Private offering	$ 50,000

Debt (Future Minimum of Debt) (

Debt (Future Minimum of Debt) (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Total debt	$ 3,636,819	$ 3,557,458
Term Notes [Member]
Debt Instrument [Line Items]
2020	3,623,809
Total debt	3,623,809
Subordinated Debt [Member]
Debt Instrument [Line Items]
2022	500,000
Total debt	$ 500,000

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Taxes [Abstract]
Income tax provision (benefit)		$ 2,168
Net operating loss carryforwards	$ 12,988,000	12,885,000
Tax credit carryforwards	$ 306,000	$ 219,000
Federal statutory income tax rate	21.00%

Income Taxes (Income Tax Provis

Income Taxes (Income Tax Provision) (Details)	12 Months Ended
	Dec. 31, 2018USD ($)
Current:
State	$ 2,168
Total current income taxes	2,168
Income tax benefit	$ 2,168

Income Taxes (Deferred Income T

Income Taxes (Deferred Income Taxes) (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Deferred income taxes:
Net operating loss carryforwards	$ 3,541,500	$ 3,144,600
Federal and state tax credit carryforward	476,100	525,000
Accruals and reserves	150,800	104,400
Stock based compensation	106,400	68,300
Patents and intangibles	5,000	12,000
Other long-term	5,400	45,300
Total long-term deferred tax assets	4,285,200	3,899,600
Deferred tax valuation allowance	(3,877,700)	(3,374,800)
Deferred tax assets, net of allowance	407,500	524,800
Property, plant and equipment	(379,900)	(478,200)
Prepaid expenses	(24,500)	(43,500)
Total deferred tax liabilities	(404,400)	(521,700)
Net deferred tax assets	$ 3,100	$ 3,100

Income Taxes (Federal Income Ta

Income Taxes (Federal Income Taxes) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Taxes [Abstract]
Tax benefit computed at statutory rate	$ (481,139)	$ (216,791)
Change in valuation allowance	502,900	202,700
State income taxes, net of federal benefit	(19,580)	1,713
Permanent differences	12,348	9,669
Tax credits (federal and state)		(7,326)
Differences on prior returns (federal and state)	$ (14,529)	12,203
Income tax benefit		$ 2,168

Employee Benefit Plans (Details

Employee Benefit Plans (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Employee Benefit Plans [Abstract]
Maximum annual contribution per employee, percent of eligible compensation	90.00%
Matching 401K contribution	$ 40,477	$ 39,039

Commitments and Contingencies_2

Commitments and Contingencies (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Commitments and Contingencies [Abstract]
Operating lease expense	$ 20,613	$ 24,033

Commitments and Contingencies_3

Commitments and Contingencies (Schedule of Future Minimum Lease Payments) (Details)	Dec. 31, 2019USD ($)
Commitments and Contingencies [Abstract]
2020	$ 18,851
2021	$ 10,996

Shareholders' Equity (Narrative

Shareholders' Equity (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Jul. 05, 2019	Jun. 28, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of common stock from treasury, shares	0
Issuance of common stock from treasury	$ 110,541	$ 75,750
Dividends declared or paid	$ 0	$ 0
Subordinated debt, warrants of common stock issued			10,000	90,000
Warrants exercisable period	3 years
Subordinated promissory notes, exercise price of warrants			$ 2.90	$ 2.90
Number of warrants expired	70,000
Options outstanding	331,165	393,500
Number of options, granted in period	45,000	195,000
Unrecognized stock based compensation expense	$ 166,820
Unrecognized stock based compensation expense, recognition period	2 years 7 months 2 days
Weighted average grant date fair value	$ 0.44
Stock Options And Non-Cash Issuance Of Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 70,133	$ 56,168
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized for issuance	15,000
Share Price	$ 3.20
Options outstanding	15,000
Number of options, granted in period	21,667
Share-based compensation expense	$ 38,583
Unrecognized stock based compensation expense, recognition period	2 months 12 days
First Anniversary [Member] | Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	1 year
The 2010 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of common stock from treasury, shares	22,181	21,734
Issuance of common stock from treasury	$ 55,791	$ 75,750
Shares authorized for issuance	500,000
Options outstanding	293,665
Number of options, granted in period	7,500
The 2010 Plan [Member] | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contractual Term	10 years
Vesting period	5 years
The 2010 Plan [Member] | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
2019 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of common stock from treasury, shares	23,420
Issuance of common stock from treasury	$ 54,750
Shares authorized for issuance	500,000
Options outstanding	37,500
Shares available for future grants	439,080
2019 Plan [Member] | Greater Than 10% Stockholders [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	5 years
2019 Plan [Member] | Less Than 10% Stockholders [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	10 years
Treasury Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of common stock from treasury, shares	45,601	21,734
Issuance of common stock from treasury	$ 124,435	$ 59,308
Warrants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of common stock from treasury, shares	0	0

Shareholders' Equity (Fair Valu

Shareholders' Equity (Fair Value of Option Grants) (Details)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected option term, years	5 years 6 months	5 years 6 months
Expected volatility factor	53.42%	16.96%
Risk-free rate	1.52%	2.36%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected option term, years	6 years	6 years 3 months
Expected volatility factor		26.87%
Risk-free rate	2.51%	2.94%

Shareholders' Equity (Stock Opt

Shareholders' Equity (Stock Option Transactions) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options, outstanding, beginning balance	393,500
Number of options, Granted	45,000	195,000
Number of options, Forfeited	(51,671)
Number of options, Expired	(55,664)
Number of options, outstanding, ending balance	331,165	393,500
Number of options, exercisable	179,824	182,164
Weighted Average Exercise Price, Outstanding, beginning of period	$ 4.89
Weighted Average Exercise Price, Granted	2.50
Weighted Average Exercise Price, Forfeited	4.04
Weighted Average Exercise Price, Expired	5.68
Weighted Average Exercise Price, Outstanding, ending of period	4.57	$ 4.89
Weighted Average Exercise Price, Exercisable	$ 5.62	$ 6.09
Weighted average remaining contractual term (in years), Outstanding	6 years 7 months 17 days	7 years 2 months 19 days
Weighted average remaining contractual term (in years), Exercisable	4 years 9 months	4 years 9 months 22 days
Aggregate Intrinsic Value, Outstanding	$ 1,050	$ 960
Aggregate Intrinsic Value, Exercisable	$ 1,050	$ 960
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options, Granted	21,667
Number of options, Forfeited	(6,667)
Number of options, outstanding, ending balance	15,000
Weighted Average Exercise Price, Granted	$ 2.58
Weighted Average Exercise Price, Forfeited	2.25
Weighted Average Exercise Price, Outstanding, ending of period	$ 3.20

Subsequent Events (Narrative) (

Subsequent Events (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Subsequent Events [Abstract]
Number of options, granted in period	45,000	195,000
Proceeds from subordinated debt	$ 500,000
Subordinated promissory notes	470,152	$ 0
Proceeds from sale of property	$ 663,334	$ 0